Clinical trial
Chlorambucil in Treating Patients With Advanced Chronic Lymphocytic Leukemia
NCT00017108 · European Organisation for Research and Treatment of Cancer - EORTC, Other · Unknown status
Key facts
| NCT number | NCT00017108 |
|---|---|
| Title | Chlorambucil in Treating Patients With Advanced Chronic Lymphocytic Leukemia |
| Official title | Low Dose Chlorambucil Maintenance Vs. No Treatment Following High-Dose Chlorambucil Induction In Patients With Advanced B-Chronic Lymphocytic Leukemia. A Randomized Phase III Study Of The EORTC LG (CLL-3) |
| Lead sponsor | European Organisation for Research and Treatment of Cancer - EORTC, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Leukemia |
| Intervention type | Drug |
| Interventions | chlorambucil, cyclophosphamide, fludarabine phosphate |
| Start date | Mar 1, 2001 |
| First posted | Jan 27, 2003 |
| Last update posted | Jul 24, 2008 |
| Countries | Belgium, Czechia, Hungary, Italy, Netherlands, North Macedonia, Portugal |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: